DescriptionThe Recombinant Human GALNT12 Protein is derived from CHO. The Recombinant Human GALNT12 Protein has been validated for the following applications: Enzyme Activity.
|colorectal cancer, susceptibility to 1, CRCS1, EC 18.104.22.168, FLJ21212, GalNAc-T12, Polypeptide GalNAc transferase 12, polypeptide N-acetylgalactosaminyltransferase 12, pp-GaNTase 12, Protein-UDP acetylgalactosaminyltransferase 12, UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12, UDP-N-acetyl-alpha-D-galactosamine:polypeptideN-acetylgalactosaminyltransferase 12 (GalNAc-T12)|
|<1.0 EU per 1μg of the protein by the LAL method.|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining|
|Observed M.W.: 58-67kDa, reducing conditions, Theoretical M.W.: 64kDa|
|Measured by its ability to transfer GalNAc from UDP-GalNAc to peptide EA2 from AnaSpec, Inc. The specific activity is >90 pmol/min/μg, as measured under the described conditions. See Activity Protocol on RnDSystems.com.|
|Chinese Hamster Ovary cell line, CHO-derived Arg38-Leu581 with a C-terminal 6-His tag|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok